Who owns MYMD PHARMACEUTICALS INC COM NEW?
- CUSIP Number: 62856x201
Tip: Access positions for across all investors
Analyze quarterly positions in Mymd Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Mymd Pharmaceuticals stock
Who bought or sold MYMD PHARMACEUTICALS INC COM NEW this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Mirae Asset Global Investments | 876k | $1.3M | 100% | Mar 2024 |
|
Vanguard Group | 31k | $73k | 100% | Mar 2024 |
|
BlackRock | 6.8k | $16k | 100% | Mar 2024 |
|
UBS Group | 2.0k | $4.8k | 100% | Mar 2024 |
|
Parallel Advisors | 838.00 | $2.0k | 100% | Mar 2024 |
|
Group One Trading | 459.00 | $1.1k | 100% | Mar 2024 |
|
Advisor Group Holdings | 266.00 | $631.404200 | 100% | Mar 2024 |
|
Morgan Stanley | 224.00 | $448.000000 | 100% | Mar 2024 |
|
Wells Fargo & Company | 177.00 | $424.800000 | 100% | Mar 2024 |
|
Sandy Spring Bank | 116.00 | $278.005600 | 100% | Mar 2024 |
|
Ancora Advisors | 90.00 | $215.001000 | 100% | Mar 2024 |
|
Harbor Investment Advisory | 90.00 | $215.001000 | 100% | Mar 2024 |
|
Royal Bank of Canada | 79.00 | $0 | 100% | Mar 2024 |
|
Newbridge Financial Services Group | 34.00 | $81.001600 | 100% | Mar 2024 |
|
Arvest Investments | 34.00 | $81.001600 | 100% | Mar 2024 |
|
Qube Research & Technologies | 3.00 | $6.999900 | 100% | Mar 2024 |
|
Bank of America Corporation | 1.00 | $2.000000 | 100% | Mar 2024 |
|
Cornerstone Planning Group | 1.00 | $4.000000 | 100% | Mar 2024 |
|